Evidence map›Paper›PMID 23263777›Full record

ArticleCancer causes & control : CCC2013

Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701).

Carolina Porras, Jesse Nodora, Rachael Sexton, Catterina Ferreccio, Silvia Jimenez, Ricardo L Dominguez, Paz Cook, Garnet Anderson, Douglas R Morgan, Laurence H Baker and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Cancer causes & control : CCC, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06318104 (Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 Days), which is not on this map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06318104 phase4unknown statusnot on this mapstarted 2024, after this paper: background citation

Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 Days

TypeinterventionalSponsorHospital General de México Dr. Eduardo LiceagaRan2024 to 2025Enrolled160ConditionsHelicobacter Pylori InfectionArmsTegoprazan, Esomeprazole 40mg
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Helicobacter pylori eradication: influence of interleukin-1beta -31 C/T polymorphism.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Trial
  6. Article
  7. Frontiers in gastroenterology (Lausanne, Switzerland) · 2026
    Article
  8. Article
  9. High Seroprevalence ofGastroenterology research · 2025
    Article
  10. Article
  11. Article
  12. Screening Probiotics for Anti-Foods (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Ethnic Disparities in Early-Onset Gastric Cancer Persist across Rural-Urban Geographies.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  15. Article
  16. Worldwide Prevalence and Risk Factors ofChildren (Basel, Switzerland) · 2022
    Review
  17. Article
  18. Article
  19. Journal of clinical medicine · 2022
    Article
  20. Epidemiology of stomach cancer.World journal of gastroenterology · 2022
    Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Carolina PorrasProyecto Epidemiológico Guanacaste, Fundación INCIENSA, Torre La Sabana, 300 mts. Oeste del ICE, planta baja frente al Lobby, Sabana Norte, San Jose, Costa Rica. cporras@proyectoguanacaste.org
Jesse Nodora
Rachael Sexton
Catterina Ferreccio
Silvia Jimenez
Ricardo L Dominguez
Paz Cook
Garnet Anderson
Douglas R Morgan
Laurence H Baker
E Robert Greenberg
Rolando Herrero
Cancer Research And Biostatistics · USInstituto Costarricense de Investigación y Enseñanza en Nutrición y Salud · CRPontificia Universidad Católica de Chile · CLUniversity of Michigan–Ann Arbor · USFred Hutch Cancer Center · USGuanacaste Conservation Area · CRUniversity of California, San Diego · US

Funding

SWOG Foreign AccrualsU10CA037429 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BLANKE, CHARLES D., MEYSKENS, FRANK L. · 1985 to 2014
$205.2M
NCI NIH HHS CA037429NCI NIH HHS U10 CA037429
6 · The paper itself

Abstract

objectiveTo investigate the potential determinants of Helicobacter pylori infection between adults 21-65 years old.

methodsData are from the initial screening visit of a randomized clinical trial of three antibiotic regimens to eradicate H. pylori, conducted in seven sites (Santiago-Chile, Túquerres-Colombia, Guanacaste-Costa Rica, Copán-Honduras, Obregón and Tapachula-México, León-Nicaragua). Thousand eight hundred and fifty-nine adults from the general population were screened for H. pylori infection using an urea breath test (UBT) and were interviewed to assess socioeconomic-, demographic-, and symptom-related characteristics. Logistic regression was used to assess the relationship between these characteristics and H. pylori positivity at enrollment.

resultsAmong the 1,852 eligible participants for whom a conclusive UBT result was obtained, H. pylori prevalence was 79.4 %, ranging from 70.1 to 84.7 % among the seven centers. Prevalence did not differ by sex (female: 78.4, male: 80.9; p = 0.20) or age (p = 0.08). H. pylori positivity increased with increasing number of siblings (p trend <0.0001). Participants with education beyond 12 years were less likely to be UBT-positive (OR 0.4: 0.3-0.6, compared to participants with 0-6 years of schooling) as were those employed outside the home (OR 0.7: 0.6-1.0). Odds of H. pylori infection increased with the presence of certain living conditions during childhood including having lived in a household with an earth floor (OR 1.8: 1.4-2.4), lack of indoor plumbing (OR 1.3: 1.0-1.8) and crowding (OR 1.4: 1.0-1.8, for having more than two persons per bedroom). Regarding current household conditions, living with more than 3 children in the household (OR 1.7: 1.2-2.5) and crowding (OR 1.8: 1.3-2.3) were associated with H. pylori infection.

conclusionsThe prevalence of H. pylori in adults was high and differed significantly among the six Latin American countries studied (p < 0.001). Our findings confirm the strong link between poor socioeconomic conditions and H. pylori infection.

Indexed as

AdultAgedClinical Trials, Phase III as TopicFemaleHelicobacter InfectionsHelicobacter pyloriHumansLatin AmericaMaleMiddle AgedMulticenter Studies as TopicRandomized Controlled Trials as TopicRisk FactorsYoung Adult

Identifiers

PMID23263777
PMCPMC3645498
OpenAlexW1994880036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.